Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
EPS (Diluted)
Vivos Therapeutics Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
EPS (Diluted)
-$11
|
CAGR 3-Years
12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
EPS (Diluted)
$9
|
CAGR 3-Years
10%
|
CAGR 5-Years
64%
|
CAGR 10-Years
10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
EPS (Diluted)
$5
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
EPS (Diluted)
$12
|
CAGR 3-Years
-19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
EPS (Diluted)
$5
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-2%
|
See Also
What is Vivos Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-11.1
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's EPS (Diluted) amounts to -11.1 USD.
What is Vivos Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
2%
Over the last year, the EPS (Diluted) growth was 57%. The average annual EPS (Diluted) growth rates for Vivos Therapeutics Inc have been 12% over the past three years , 2% over the past five years .